(CIDRAP News) An international avian and pandemic flu meeting in Hanoi concluded yesterday, with health ministers and top officials from more than 70 countries agreeing on a set of strategies for responding to future disease threats.
(CIDRAP News) A group of international donors who met yesterday in the final session of an avian influenza conference in Sharm el-Sheikh, Egypt, pledged more support for avian and pandemic flu preparedness and prevention, led by $320 million from the United States.
(CIDRAP News) – An H5N1 influenza vaccine made by the British pharmaceutical company GlaxoSmithKline (GSK) has become the first prepandemic vaccine to be licensed by the European Union (EU), the company announced today.
(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.
(CIDRAP News) Outbreaks of H5N1 avian influenza in 15 countries since December 2007 are a potent reminder that the virus is still a global threat, the United Nations Food and Agriculture Organization (FAO) warned today, as officials in Thailand announced they found the disease in poultry again after a 6-month lapse.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.